Cerity Partners
ANGO icon

Cerity Partners’s AngioDynamics ANGO Stock Holding History

Cerity Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192K Buy
16,857
+2,547
+18% +$27.6K ﹤0.01% 2894
2025
Q4 		$184K Buy
14,310
+2,813
+24% +$34.7K ﹤0.01% 2654
2025
Q3 		$128K Sell
11,497
-862
-7% -$8.32K ﹤0.01% 2591
2025
Q2 		$123K Sell
12,359
-570
-4% -$5.58K ﹤0.01% 2448
2025
Q1 		$121K Buy
12,929
+2,333
+22% +$24.5K ﹤0.01% 2300
2024
Q4 		$87K Sell
10,596
-12,266
-54% -$90.2K ﹤0.01% 2349
2024
Q3 		$178K Buy
+22,862
New +$165K ﹤0.01% 2343
2024
Q2 		– Sell
-13,526
Closed -$79.4K – 2234
2024
Q1 		$79.4K Buy
+13,526
New +$80.4K ﹤0.01% 2224

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Cerity Partners's ANGO Position: Q1 2026 in Review

Cerity Partners increased its AngioDynamics (ANGO) stake by 18% in Q1 2026, buying an estimated $27.6K and bringing the position to 16,857 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #2894.

Cerity Partners first reported a position in ANGO in Q1 2024 and has held it in 8 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Cerity Partners held 16,857 shares of AngioDynamics worth $192K as of Q1 2026.
  • Cerity Partners bought 2,547 AngioDynamics shares in Q1 2026, an estimated $27.6K.
  • AngioDynamics made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2894 holding.
  • Cerity Partners first reported a position in AngioDynamics in Q1 2024 and has held it in 8 quarters since.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.